To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia.
To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia.
Haematologica. 2020 Jun;105(6):1470-1472
Authors: Sallman DA
PMID: 32482751 [PubMed - in process]
Source: Haematologica - Category: Hematology Authors: Sallman DA Tags: Haematologica Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Myelodysplastic Syndrome